Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 105 for “"HGSOC"”.
-
HGSOC subtypes and treatment interaction : implications for clinical implementation of the PrOTYPE classifier
High-grade serous ovarian cancer (HGSOC) represents approximately 70% of cases of ovarian carcinoma. Investigation into its molecular features led to the discovery of four subtypes of HGSOC, which differ from each other in their gene expression, cellular composition and survival outcomes. However, …
-
scRNA-seq to characterise the tumour microenvironment of high grade serous ovarian carincoma (HGSOC)
High Grade Serous Ovarian Carcinoma (HGSOC) is the most common type of ovarian cancer. Patients with this disease typically experience relapse in their disease following surgical debulking and initially effective chemotherapy. HGSOC has been intensely studied at the genomic and transcriptomic …
-
Understanding tumour heterogeneity of HGSOC to predict progression and novel therapeutic approaches to improve patient survival
… dealing with high-grade serous ovarian cancer (HGSOC). Due to unspecific symptoms, HGSOC is often diagnosed at late stage when the disease has spread throughout the peritoneal cavity. Even with surgical intervention and platinum-based chemotherapy, the five-year survival rate is below 40%, and …
-
Investigating lipid metabolism and gene expression in High Grade Serous Ovarian Cancer (HGSOC) disease progression and chemoresistance
HGSOC is the most common and deadly form of ovarian cancer and is characterised by vague symptoms, late diagnosis and a high level of metastasis. While most patients initially respond well to the current standard of treatment – tumour debulking surgery and platinum/taxane combination chemotherapy – …
-
FUNCTIONAL CHARACTERIZATION AND MODELING OF FACTORS INVOLVED IN HIGH GRADE SEROUS OVARIAN CARCINOMA INITIATION
High grade serous ovarian carcinoma (HGSOC) is the most lethal form of ovarian cancer and is the fifth leading cause of female death in the western world. Unlike many other cancers, few viable HGSOC screening methodologies exist. HGSOC is consequently diagnosed at an advanced stage with substantial …
-
TOWARDS PATIENT-SPECIFIC MODELS IN HIGH GRADE SEROUS OVARIAN CANCER (HGSOC): LINKING EPIGENETIC TRACING OF CELL OF ORIGIN WITH ACTIONABLE ORGANOID MODELS
… Patients with high-grade serous ovarian cancer (HGSOC), representing the largest majority of OC (~70%), have not experienced significant improvement in overall survival in last decades (1), pointing to the acute need to identify new predictive biomarkers and therapeutic targets for clinical …
-
High resolution analysis of the tumour microenvironment of high grade serous ovarian cancer (HGSOC) using single cell transcriptomics and quantitative histopathological examination
… with high grade serous ovarian carcinoma (HGSOC) accounting for more than 70% of all OC deaths. Although the prognosis for HGSOC patients has shown some improvement over the last 30 years with an overall five-year survival increasing from 31% to 46%, the disease remains highly recurrent …
-
Characterizing chromosome instability in chemonaïve, chemosensitive and chemoresistant high-grade serous ovarian cancer
High-grade serous ovarian cancer (HGSOC) is the most common and lethal gynaecological malignancy in women. The high level of mortality in HGSOC patients is attributed to late stage diagnoses, highly aggressive metastatic disease, disease recurrence and drug resistance. Currently, little is known …
-
Identification of candidate susceptibility genes in the rarer histotypes of epithelial ovarian cancer
… most common histotype, high-grade serous cases (HGSOC). Determining risk factors for the rarer, non-HGSOC histotypes (low-grade serous (LGSOC), endometrioid (ENOC), clear cell (CCOC), and mucinous (MOC)) has been challenging due to limited sample sizes. This thesis used resources from a large …
-
The role of the piRNA pathway genes in ovarian and prostate cancer progression
… cancers, high grade serous ovarian (HGSOC) and prostate (PCa) cancer. We showed dissimilar expression of 10 piRNA pathway genes (PIWIL1- 4, DDX4, HENMT1, MAEL, PLD6, TDRD1 and TDRD9) in clinical HGSOC and PCa samples. In HGSOC, we discovered that genes involved in the primary and …
-
Investigating the role of the UbcH10 proto-oncogene product in high grade serous ovarian cancer
High grade serous carcinoma (HGSOC) is the 5th leading cause of cancer related deaths in females worldwide. According to the Cancer Genome Atlas (TCGA), HGSOC is marked by early TP53 mutation and has four molecular subtypes; Mesenchymal, Immunoreactive, Proliferative and Differentiated. Despite …
-
The Role of Ifitm3 In The Immune Response of Brca-Deficient High Grade Serous Ovarian Carcinoma
… high grade serous ovarian carcinoma (HGSOC) had increased tumor infiltrating lymphocytes (TILs) compared to BRCA-wildtype (WT). To better understand the underlying immune mechanism in these tumors, a preliminary transcriptome analysis was performed on a set of microdissected HGSOC …
-
Evaluating the impact diminished SKP1 and CUL1 expression have on chromosome instability and high-grade serous ovarian cancer pathogenesis
High-grade serous ovarian cancer (HGSOC) is the most common and lethal ovarian cancer subtype. Chromosome instability (CIN; an increased rate of chromosome gains and losses) is believed to play a fundamental role in the development and evolution of HGSOC. The current study aims to evaluate the …
-
Investigating Mechanisms of Intrinsic Chemoresistance in High Grade Serous Ovarian Cancer
High grade serous ovarian cancer (HGSOC) is the most common type of ovarian cancer (OC) and is responsible for the most OC deaths. Poor long-term survival in HGSOC patients is due to late-stage diagnosis and resistance to chemotherapy (chemoresistance). At 1st line, HGSOC patients are typically …
-
NON-CODING RNAS IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER
… High-grade serous ovarian carcinoma (HGSOC) is the most lethal gynecologic malignancy, mainly because the disease is frequently diagnosed at an advanced stage and is characterized by the early onset of chemoresistant recurrences. The lack of reliable diagnostic and prognostic markers, …
-
EPIGENETICS AND HISTONE UBIQUITINATION IN OVARIAN CANCER
… High grade serous ovarian carcinoma (HGSOC) is the most common histotype of EOC. Unfortunately, it is typically detected at advanced stages and has a 5-year survival rate of less than 30%. A less common subtype but no less formidable is clear cell ovarian cancer (CCOC). This subtype, …
-
Genomic catastrophes: complex structural variants in high grade serous ovarian cancer
High-grade serous ovarian cancer (HGSOC) is the most common and lethal type of ovarian cancer. HGSOC accounts for 70-80% of deaths from all forms of ovarian cancer, roughly 98000-110000 deaths worldwide each year according to WHO estimates. It is characterized by ubiquitous mutations in the tumour …
-
Evaluation von LRP1B als prognostischer Marker für das high-grade seröse Tuboovarialkarzinom
Das high-grade seröse Tuboovarialkarzinom (HGSOC) weist seit Jahren eine stabil schlechte Prognose auf, gekennzeichnet durch eine frühe peritoneale Metastasierung. Zur Optimierung der klinischen Diagnostik und Therapie ist eine Identifikation von weiteren Risikofaktoren nötig, auch als mögliche …
-
Identifying and overcoming mechanisms of resistance to Wee1 kinase inhibitor (AZD1775) in high grade serous ovarian cancer
High grade serous ovarian cancer (HGSOC) comprises 75-80% of all ovarian cancer cases and is characterised by p53 mutation and genetic heterogeneity. There are two major molecular categories: homologous recombination repair (HR) pathway proficient and deficient. Most cases are treated with a …
-
Understanding Ovarian Cancer Risk: Pathogenic TP53 mutation burden in peritoneal fluid is associated with BRCA germline mutation status
… of developing high-grade serous ovarian cancer (HGSOC), the most common and deadliest subtype of ovarian cancer. While HGSOC is initiated by TP53 mutations, these mutations are also now recognized as a common feature of normal human aging. We hypothesize that BRCA carriers harbor increased TP53 …
Page 1 of 6